covid
Buscar en
Allergologia et Immunopathologia
Toda la web
Inicio Allergologia et Immunopathologia The evaluation of neutrophil–lymphocyte ratio in children with asthma
Información de la revista
Vol. 44. Núm. 4.
Páginas 292-296 (julio - agosto 2016)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
6021
Vol. 44. Núm. 4.
Páginas 292-296 (julio - agosto 2016)
Original Article
Acceso a texto completo
The evaluation of neutrophil–lymphocyte ratio in children with asthma
Visitas
6021
M. Dogru
Autor para correspondencia
mdmahmut@yahoo.com

Corresponding author.
, R.G. Yesiltepe Mutlu
Zeynep Kamil Woman's and Children's Diseases Training and Research Hospital, Department of Pediatrics, Istanbul, Turkey
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Tablas (2)
Table 1. Comparison of socio-demographic and neutrophil–lymphocyte ratio between patients and control groups.
Table 2. Comparison of socio-demographic features, clinical and laboratory findings of the patient groups.
Mostrar másMostrar menos
Abstract
Background

Neutrophil–lymphocyte ratio (NLR) is a test used to evaluate the systemic inflammation. There is little knowledge about the neutrophil–lymphocyte ratio in asthmatics. In our study, we aimed to evaluate NLR and to assess its relationship with clinical parameters in children with asthma.

Methods

Four hundred and sixty-nine children diagnosed with asthma and followed in our hospital were included in the study. The control group included 170 children with no evidence of allergic disease (i.e. asthma, allergic rhinitis, eczema) or infection. Skin prick tests were performed using the same antigens for all patients. The immunoglobulin E levels and complete blood count were measured.

Results

There was no difference between the groups with regard to gender and age. Mean NLR was 2.07±1.41 in the study group and 1.77±1.71 in the control group. The difference was statistically significant (p=0.043). There was no statistically significant difference between NLR and gender, familial atopy, exposure to smoke, sensitivity to allergens (p>0.05). While mean NLR was weakly positively correlated with number of hospitalisations (r: 0.216; p: 0.012), the percentage of eosinophils was weakly negatively correlated with NLR (r: −0.195; p: 0.001).

Conclusion

Mean NLR is higher in asthmatic children compared to control group. We think that NLR could be used for the evaluation of systemic inflammation in asthmatic patients. However, further studies are needed to assess airway and systemic inflammation as well as NLR in patients with asthma.

Keywords:
Neutrophil–lymphocyte ratio
Children
Asthma
Hospitalisation
Eosinophil
Texto completo
Introduction

Asthma is a chronic respiratory disease which affects 1–18% of the population in different countries. It is defined as a chronic inflammation of airways characterised by increased responsiveness of bronchials to a variety of stimuli. It is characterised by recurrent attacks of cough, wheezing, dyspnoea and by variable expiratory airflow limitation.1 In addition to airway inflammation, there is a systemic inflammation in asthma. The increased circulating proinflammatory cytokines, such as interleukin (IL)-6 and tumour necrosis factor-α (TNF-α) play a role in this inflammation. These proinflammatory cytokines in asthmatic patients increase in immune cells, such as neutrophils and natural killer cells, and stimulate hepatic production of acute-phase proteins, such as C-reactive protein (CRP). C-reactive protein is known to be a sensitive marker of low-grade systemic inflammation.2,3 C-reactive protein is the most commonly used marker to evaluate the systemic inflammation in patients with asthma.3–9 Results with CRP levels in patients with asthma are inconsistent. Although some studies showed no difference in comparison with the control group,3,4 there are also some studies that observe CRP levels as higher in asthmatics than the control group.5–9 In addition to CRP, other acute phase reactants such as serum amyloid A and fibrinogen were evaluated in assessing the systemic inflammation in patients with asthma.5

Neutrophil–lymphocyte ratio (NLR) could be an important measure of systemic inflammation as it is readily available, cost effective and could be calculated easily. NLR may reflect ethnicity, neurohumoral activation, renal dysfunction, thyroid disease, hepatic dysfunction, nutritional deficiencies, bone marrow dysfunction, inflammatory diseases, chronic or acute systemic inflammation.10 NLR has been associated with some conditions such as chronic inflammation in cardiovascular diseases, hypertension, diabetes mellitus, malignancies, FMF, hepatic cirrhosis, and Behcet Disease, and it has been suggested that NLR has a prognostic importance.11–16 There is also a chronic inflammation in asthma. Cytokines in the pathogenesis of asthma cause an increase in neutrophils, as noted above.3 Based on this information, we think that the neutrophil–lymphocyte ratio is increased in asthmatics. However, our knowledge about NLR in asthmatic patients is less.11,17 While one of these studies performed in adults, showed no relationship between asthma and NLR,11 NLR was found to be associated with neutrophilic asthma in the other study.17

In our study, we aimed to evaluate NLR and to assess its relationship with clinical parameters in children with asthma.

Methods

Four hundred and sixty-nine children with asthma, followed in the Paediatric Allergy and Immunology Department of a public hospital of Obstetrics and Paediatrics, were included in the study. Patients were evaluated retrospectively between September 2012 and November 2014. The control group included 170 children with no evidence of allergic disease (i.e. asthma, allergic rhinitis, eczema) or infection.

Patients who have had an exacerbation of asthma, receiving systemic steroids within the last month, acute/chronic infection, and patients with any other systemic disease such as hepatic, renal, cardiovascular diseases, diabetes mellitus, cancer and systemic inflammatory disorders were excluded. In addition, patients with anaemia/polycythemia, leukopenia/leukocytosis, and thrombocytopenia/thrombocytosis in complete blood count analysis were excluded from the study. Neutrophil–lymphocyte ratio may be changed by medications such as Nebivolol.18 Therefore, patients receiving Nebivolol were excluded. A detailed allergic history, including the age, a familial atopy history, and exposure to cigarette smoke were recorded. Familial atopy was accepted as positive when having allergic disease in first degree relatives (parents and siblings). The diagnosis of asthma was evaluated according to the GINA guidelines.1 The immunoglobulin (Ig) E levels and complete blood count were measured. The study was approved by the Zeynep Kamil Woman's and Children's Diseases Training and Research Hospital Ethics committee and an oral consent was obtained from all subjects and/or their parents.

Skin prick tests

Skin prick tests were performed using the same antigens for all patients. Patients were considered eligible for the skin test if they have not received antihistamines for at least one week. Skin prick tests were applied on the anterior forearm. Histamine (10mg/ml) and physiological saline were used as positive and negative controls, respectively. Skin reactions were evaluated at the 15th minute of the application, and indurations ≥3mm were considered as a positive reaction. Skin prick tests for common aeroallergens (Dermatophagoides pteronyssinus, Dermatophagoides farinea, grass mix, cereal mix, tree mix, weed mix, Alternaria alternaria, cockroaches, cat dander and dog dander (Stallergenes SA, 92160 Antony, France) were performed by using stallerpoint (Stallergenes SA, 92160 Antony, France).

Laboratory analysis

Haemoglobin, platelet, leucocyte, neutrophil, and lymphocyte count measurements were performed within approximately 60min after blood sampling with Coulter LH 780 Analyzer and Coulter Hmx Haematology Analyzer (Beckman Coulter, Inc., CA, USA) with original method and reagents. Neutrophil–lymphocyte ratio was calculated by dividing the percentage of neutrophils and lymphocytes in complete blood count analysis.

Statistical analyses

Statistical Package for Social Sciences (SPSS for Windows 15.0, Chicago, USA) programme was used to analyse the data. Results were given as either mean±standard deviation (SD) or as mean±standard deviation (median) according to the distribution. Student's t test was used for the comparison of normally distributed variables. Chi-square and Mann–Whitney U tests were used for non-normally distributed variables. Pearson's correlation test was used for the correlation analyses of continuous variables. p<0.05 was considered as significant.

Results

The demographic and NLR of the study population are shown in Table 1. There was no difference between the groups with regard to gender and age. Mean NLR was 2.07±1.41 in the study group and 1.77±1.71 in the control group. The difference was statistically significant (p=0.043) (Table 1).

Table 1.

Comparison of socio-demographic and neutrophil–lymphocyte ratio between patients and control groups.

  Study group (n=469)  Control group (n=170)  p 
Gender (n)
Male/female  266/203  90/80  0.418* 
Age (years)
Mean±standard deviation  8.58±3.25  8.71±3.03  0.436** 
Minimum–maximum (median)  5–18 (7.4)  5–18 (8.2)   
Neutrophillymphocyte ratio
Mean±standard deviation  2.07±1.41  1.77±1.71  0.043** 
*

Chi-squared.

**

Mann–Whitney U test.

There was no statistically significant difference between NLR and gender, familial atopy, exposure to smoke, sensitivity to allergens (p>0.05) (Table 2).

Table 2.

Comparison of socio-demographic features, clinical and laboratory findings of the patient groups.

  Neutrophil–lymphocyte ratio  p 
Gender    0.873*
Male  2.15±2.54 (1.41) 
Female  1.97±2.35 (1.40) 
The presence of familial atopy    0.143*
Yes  1.77±1.49 (1.39) 
No  2.34±3.03 (1.46) 
Exposure to smoke    0.938*
Yes  2.02±2.39 (1.40) 
No  2.14±2.56 (1.42) 
Sensitivity in skin prick test (atopy)    0.173*
Yes  2.29±2.91 (1.42) 
No  1.75±1.56 (1.38) 
Sensitivity to house dust mite    0.397*
Yes  2.30±3.01 (1.41) 
No  1.80±1.55 (1.39) 
Sensitivity to pollens    0.540*
Yes  2.00±2.29 (1.40) 
No  2.36±3.10 (1.41) 
Sensitivity to dander    0.947*
Yes  2.18±2.72 (1.33) 
No  2.05±2.42 (1.41) 
Sensitivity to A. alternata    0.306*
Yes  1.56±0.98 (1.36) 
No  2.08±2.49 (1.41) 
Sensitivity to cockroach    0.348*
Yes  2.87±3.54 (1.85) 
No  2.41±2.35 (1.39) 

Mean± standard deviation (median).

*

Mann–Whitney U test.

While mean NLR was weak positively correlated with number of hospitalisation (r: 0.216; p: 0.012), the percentage of eosinophil was weakly negatively correlated with NLR (r: −0.195; p: 0.001).

Discussion

This study demonstrates for the first time that mean NLR in children with asthma is higher than healthy controls. The data about NLR in asthmatic patients is inadequate.11,17 In one of these studies, Imtiaz et al.11 investigated the relationship between the NLR and chronic diseases such as hypertension, diabetes mellitus, asthma and arthritis in adults. They did not find a relationship between NLR and asthma. However, the diagnosis of asthma was ascertained by self-reporting in this study and NLR was not compared with control group. Therefore, their results may be in contradiction with our results. In the other study, Zhang et al.17 evaluated eosinophil and neutrophil percentages in sputum cytology and blood count of 164 patients with uncontrolled asthma. In this study, they determined that NLR increased in neutrophilic asthma. They concluded that neutrophilic asthma could also be detected by blood neutrophil percentages and NLR, but with less accuracy. Blood counts may be a useful aid in the monitoring of uncontrolled asthma.17 We could not evaluate the sputum cytology of asthmatic patients in our study. As mentioned in the introduction, we hypothesised that the neutrophil–lymphocyte ratio of asthmatic is high. In accordance with our hypothesis, we found that NLR in asthmatic children was higher compared to control.

Another important result of our study is that mean NLR was weakly positively correlated with number of hospitalisations. The relationship between NLR and the number of hospitalisations has not been evaluated before in the literature. But Schleich et al.19 reported a statistically significant correlation between sputum and percentage blood neutrophils. Zhang et al.17 similarly demonstrated that NLR (so neutrophils) was high in patients with neutrophilic asthma. Although we did not assess sputum cytology; taking into consideration the above results, we can predict that neutrophils in the sputum of patients with increased NLR is high. Furukawa et al.20 observed that enterance of asthmatic children with increased sputum neutrophils to emergency was higher. Consistent with this study, we found that mean NLR was weak positively correlated with number of hospitalisation. Additionally, systemic inflammation is more frequent in patients with neutrophilic asthma.7,8 In the study of Fu et al.21 they evaluated systemic inflammation in 50 asthmatic adults. They found that the number of neutrophils in sputum was more in the asthmatics with systemic inflammation (increased CRP and IL-6). In addition to this study, Gunay et al.22 investigated the NLR of 269 patients with COPD and showed that there was a positive correlation between CRP and NLR. Due to the reasons that neutrophils in the blood and NLR have a relation with the number of neutrophils in sputum, the systemic inflammation in neutrophilic asthmatics is high and there is a positive correlation between the NLR and CRP; we think that NLR may be used in the evaluation of systemic inflammation in asthma as well because it is easy, cost effective and could be calculated easily.

There are several potential limitations to this study. Firstly, other inflammatory parameters such as CRP in evaluating the systemic inflammation could not be evaluated in our patients. Secondly, we could not assess airway inflammation and sputum cytology in our patients. These investigations could not be done because our study was done retrospectively. Despite these limitations, to our knowledge, it is the first study which assesses the relationship between NLR and asthma in such a large population in childhood.

In conclusion, mean NLR is higher in asthmatic children compared to the control group. We think that NLR could be used for the evaluation of systemic inflammation in asthmatic patients. But further studies are needed to assess airway and systemic inflammation as well as NLR in patients with asthma.

Ethical disclosuresProtection of human subjects and animals in research

Protection of human and animal subjects. The authors declare that the procedures followed were in accordance with the regulations of the responsible Clinical Research Ethics Committee and in accordance with those of the World Medical Association and the Helsinki Declaration.

Patients’ data protection

Confidentiality of data. The authors declare that they have followed the protocols of their work centre on the publication of patient data and that all the patients included in the study have received sufficient information and have given their informed consent in writing to participate in that study.

Right to privacy and informed consent

The authors have obtained the informed consent of the patients and/or subjects mentioned in the article. The author for correspondence is in possession of this document.

Conflict of interest

None declared.

References
[1]
Global Initiative for Asthma: Global Strategy for Asthma Management and Prevention. Updated May 2014.
[2]
H. Brüünsgaard, B.K. Pedersen.
Age-related inflammatory cytokines and disease.
Immunol Allergy Clin North Am, 23 (2003), pp. 15-39
[3]
J.J. Fu, V.M. McDonald, P.G. Gibson, J.L. Simpson.
Systemic inflammation in older adults with asthma-COPD overlap syndrome.
Allergy Asthma Immunol Res, 6 (2014), pp. 316-324
[4]
L. Tilemann, L. Gindner, F. Meyer, J. Szecsenyi, A. Schneider.
Differences in local and systemic inflammatory markers in patients with obstructive airways disease.
Prim Care Respir J, 20 (2011), pp. 407-414
[5]
P. Jousilahti, V. Salomaa, K. Hakala, V. Rasi, E. Vahtera, T. Palosuo.
The association of sensitive systemic inflammation markers with bronchial asthma.
Ann Allergy Asthma Immunol, 89 (2002), pp. 381-385
[6]
M. Navratil, D. Plavec, S. Dodig, Z. Jelcic, B. Nogalo, D. Erceg, et al.
Markers of systemic and lung inflammation in childhood asthma.
J Asthma, 46 (2009), pp. 822-828
[7]
L.G. Wood, K.J. Baines, J. Fu, H.A. Scott, P.G. Gibson.
The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma.
Chest, 142 (2012), pp. 86-93
[8]
T. Shimoda, Y. Obase, R. Kishikawa, T. Iwanaga, A. Miyatake, S. Kasayama.
The fractional exhaled nitric oxide and serum high sensitivity C-reactive protein levels in cough variant asthma and typical bronchial asthma.
Allergol Int, 62 (2013), pp. 251-257
[9]
H. Kilic, A. Karalezli, H.C. Hasanoglu, O. Erel, C. Ates.
The relationship between hs-CRP and asthma control test in asthmatic patients.
Allergol Immunopathol (Madr), 40 (2012), pp. 362-367
[10]
S. Balta, T. Celik, D.P. Mikhailidis, C. Ozturk, S. Demirkol, M. Aparci, et al.
The relation between atherosclerosis and the neutrophil–lymphocyte ratio.
Clin Appl Thromb Hemost, (2015),
[11]
F. Imtiaz, K. Shafique, S.S. Mirza, Z. Ayoob, P. Vart, S. Rao.
Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population.
Int Arch Med, 5 (2012), pp. 2
[12]
M. Biyik, R. Ucar, Y. Solak, G. Gungor, I. Polat, A. Gaipov, et al.
Blood neutrophil-to-lymphocyte ratio independently predicts survival in patients with liver cirrhosis.
Eur J Gastroenterol Hepatol, 25 (2013), pp. 435-441
[13]
A.U. Uslu, K. Deveci, S. Korkmaz, B. Aydin, S. Senel, E. Sancakdar, et al.
Is neutrophil/lymphocyte ratio associated with subclinical inflammation and amyloidosis in patients with familial Mediterranean fever?.
Biomed Res Int, 2013 (2013), pp. 185317
[14]
H. Kayadibi, E. Sertoglu, M. Uyanik, S. Tapan.
Neutrophil–lymphocyte ratio is useful for the prognosis of patients with hepatocellular carcinoma.
World J Gastroenterol, 20 (2014), pp. 9631-9632
[15]
E. Sahan, S. Polat.
Neutrophil to lymphocyte ratio is associated with more extensive, severe and complex coronary artery disease and impaired myocardial perfusion.
Turk Kardiyol Dern Ars, 42 (2014), pp. 415
[16]
C. Ozturk, S. Balta, I. Balta, S. Demirkol, T. Celik, T. Turker, et al.
Neutrophil–lymphocyte ratio and carotid-intima media thickness in patients with Behçet disease without cardiovascular involvement.
Angiology, 66 (2015), pp. 291-296
[17]
X.Y. Zhang, J.L. Simpson, H. Powell, I.A. Yang, J.W. Upham, P.N. Reynolds, et al.
Full blood count parameters for the detection of asthma inflammatory phenotypes.
Clin Exp Allergy, 44 (2014), pp. 1137-1145
[18]
F. Fici, T. Celik, S. Balta, A. Iyisoy, M. Unlu, S. Demitkol, et al.
Comparative effects of nebivolol and metoprolol on red cell distribution width and neutrophil/lymphocyte ratio in patients with newly diagnosed essential hypertension.
J Cardiovasc Pharmacol, 62 (2013), pp. 388-393
[19]
F.N. Schleich, M. Manise, J. Sele, M. Henket, L. Seidel, R. Louis.
Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation.
BMC Pulm Med, 13 (2013), pp. 11
[20]
T. Furukawa, T. Sakagami, T. Koya, T. Hasegawa, H. Kawasaki, Y. Kimura, et al.
Characteristics of eosinophilic and non-eosinophilic asthma during treatment with inhaled corticosteroids.
J Asthma, 11 (2014), pp. 1-6
[21]
J.J. Fu, K.J. Baines, L.G. Wood, P.G. Gibson.
Systemic inflammation is associated with differential gene expression and airway neutrophilia in asthma.
OMICS, 17 (2013), pp. 187-199
[22]
E. Gunay, S. Sarınç Ulaşlı, et al.
Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study.
Inflammation, 37 (2014), pp. 374-380
Copyright © 2015. SEICAP
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.aller.2020.05.005
No mostrar más